News

Last week, more than 200 faculty, staff, and trainees from across the nation attended the Gill Heart & Vascular Institute's Cardiovascular Research Day to share the latest research on cardiovascular health.

The Kentucky Neuroscience Clinical-Translational Research Symposium will provide basic, translational and clinical neuroscience investigators an opportunity to discuss their work, share progress and develop collaborations.

The research building — funded half from the state of Kentucky and half from university resources, including private gifts — will house multidisciplinary research teams focusing on the Commonwealth’s most dire health disparities including cancer, diabetes and obesity, cardiovascular diseases and stroke and substance abuse.

A research facility expressly devoted to addressing and eradicating the state’s most significant health disparities was opened September 21st by the University of Kentucky Board of Trustees, President Eli Capilouto and many of the Commonwealth’s leading policymakers.

The University of Kentucky College of Pharmacy will host its ninth annual Therapeutics, Outcomes, Discovery & Delivery (TODD) Symposium from 8 a.m. to 5:30 p.m. on Thursday, Sept. 6, 2018, in room 124 of the Lee T. Todd, Jr. Building.

The UK Markey Cancer Center announced Friday that the National Cancer Institute renewed its national cancer center designation for the next five years. Markey remains one of only 70 NCI-designated centers in the country and the only one in Kentucky.

Central Kentucky producers can learn a lot at the UK Horticulture Farm's Twilight Tour July 26.

Ninety-two UK undergraduates submitted their research abstracts, hoping for the honor of personally presenting their research at the 2018 National Conference on Undergraduate Research.

As the UK Superfund Research Center continues its important work in helping to mitigate the environmental impacts on people resulting from hazardous waste sites, it is doing so on an international, as well as a national basis.

The Kentucky Cancer Registry (KCR) has received a $2.6 million contract from the National Cancer Institute (NCI) to continue its participation in the NCI’s Surveillance Epidemiology and End Results (SEER) program.